Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2005

Feb 23, 2005

29777_dirs_2005-02-23_31f84849-a263-4787-b997-8dbaf267622e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-02-18

Reporting Person: GONZALEZ RICHARD A (Director, President and COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-02-18 Common shares without par value A 46400 $46.34 Acquired 297400 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-02-18 Option (right to buy) $46.34 A 313200 Acquired 2015-02-17 common shares (313200) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 17071 Indirect
Common shares without par value 15266 Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2005.

F3: The reporting person disclaims beneficial ownership of all securities held by his wife.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 104,400 on 2/18/06, 104,400 on 2/18/07 and 104,400 on 2/18/08.